GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pharmx Technologies PHX.AX · AUD

Information Technology · ASX · 🇦🇺 Australia

Compare

0.06

-1.54%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$7.6m

FY2017FY2026

Net income

−A$1.8m

FY2017FY2026

Free cash flow

A$805,000

FY2017FY2026

Shareholders' equity

A$23.3m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$7.6mA$7.3mA$6.5mA$6.0mA$11.9mA$12.7mA$9.1mA$10.1mA$11.2mA$13.5m
Research and development—A$324,000A$144,000A$85,000A$431,000A$615,000A$588,000A$428,000A$617,000A$2.3m
Operating income−A$2.1m−A$1.4m−A$1.4m−A$774,000A$340,000A$1.5mA$2.0mA$4.0m−A$740,000A$643,000
Net income−A$1.8m−A$264,000−A$1.8m−A$1.1mA$252,000A$1.1mA$176,000−A$4.2mA$251,000−A$5.9m
Diluted earnings per share-0.00-0.00-0.00-0.000.000.000.00-0.020.00-0.02

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$27.3mA$18.8mA$29.9mA$36.5mA$30.8mA$31.3mA$19.2mA$15.0mA$19.7mA$19.8m
Cash and short-term investmentsA$2.6mA$4.2mA$13.1mA$12.8mA$5.8mA$6.5mA$2.3mA$2.3mA$5.0mA$8.1m
Total liabilitiesA$4.0mA$2.9mA$13.9mA$14.3mA$7.6mA$8.4mA$6.0mA$5.0mA$5.5mA$5.8m
DebtA$540,000A$894,000A$240,000A$32,000A$326,000A$321,000A$733,000———
Shareholders' equityA$23.3mA$15.9mA$16.0mA$22.2mA$23.2mA$22.9mA$13.2mA$10.0mA$14.2mA$14.0m
Shares outstanding629m599m599m599m597m597m597m270m270m270m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsA$825,000−A$8.1mA$3.2mA$10.9mA$2.2mA$3.2mA$369,000A$1.3mA$332,000A$249,000
Capital spending−A$20,000−A$28,000−A$1.6m−A$3.4m−A$4.0m−A$4.1m−A$3.3m−A$3.4m−A$3.5m−A$2.1m
Free cash flowA$805,000−A$8.2mA$1.6mA$7.6m−A$1.8m−A$927,000−A$2.9m−A$2.1m−A$3.1m−A$1.9m
Dividends paid—————−A$896,000−A$896,000−A$896,000−A$896,000—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.2%-9.7%-6.9%
Operating income39.3%——
Net income20.2%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-23.5%-20.6%-7.3%3.2%
Net margin-14.0%-17.9%-6.9%-11.8%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-23.8-363.0-25.0-23.473.533.9311.9-5.133.4-1.1
Price to sales5.713.16.84.11.62.96.02.10.80.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 28 Nov 2023.

FY2024FY2015FY2014FY2013FY1994FY1992FY1991
Paid in the year0.0080.0050.0170.0062.4594.592.131
  • 10-to-1 reverse split · 31 Oct 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.